Abstract-Recently, a method for assigning the probability of disease onset to all people, those clinically ill as well as those without prevalent disease has been described and termed the Oxidative Stress Index (OSI). The OSI, as originally formatted, does not predict which disease will more likely develop, only that further disease is predicted with increased OSI. It is hypothesized here that the OSI may be used to demonstrate which parameters are more contributory to the onset of a particular disease if it is measured at the time of onset of that disease. To test this hypothesis, the OSI has been reformatted to serve in that capacity for Alzheimer's disease (AD) with the anticipation that the OSI could serve to predict not only the likelihood of onset, but also identify those parameters that are most contributory to AD.
I. INTRODUCTION
People with chronic diseases and those who are disease free but living unhealthy lifestyles are known to be candidates for numerous non-communicative diseases, as well as more frequent and more severe bouts with infectious diseases. Recently, a method for assigning the probability of disease onset to all people, those clinically ill as well as those without prevalent disease has been described and termed the Oxidative Stress Index (OSI). This method is a non-invasive diagnostic protocol based upon a questionnaire addressing oxidative stress (OS) elevating factors that include disease status, lifestyle and environmental exposure with the sum of the positive answers equal to the OSI [Zeliger, 2017] .
The OSI, as originally formatted, does not predict which disease will more likely develop, only that further disease is predicted with increased OSI. It is hypothesized here that the OSI may be used to demonstrate which parameters are more contributory to the onset of a particular disease if it is measured at the time of onset of that disease. To test this hypothesis, the OSI has been reformatted to serve in that capacity for Alzheimer's disease (AD) with the anticipation that the OSI could serve to predict not only the likelihood of onset, but also identify those parameters that are most contributory to AD.
II. METHODS
The hypothesis proposed here is based upon a literature review of published studies on the causes of OS, parameters associated with the onset of AD, OS induced disease, 
III. RESULTS

A. Oxidative Stress
It is well known that all disease is accompanied by elevated OS, a property whose status can be measures by a number of biomarkers, including F2-Isoprostanes, lipid hydroxides and hydroperoxides, hydroxycholesterols, aldehydes and ketones [Zeliger, 2016] . Of these, the most widely used is malondialdehyde (MDA), which is stable in serum, as well as readily and accurately analyzed for [Nielsen, et al, 1997] . MDA level, however, can vary widely depending upon food eaten, environmental exposures, state of one's health or even the time of day when serum is drawn [Nielsen, et al, 1997] . The OSI questionnaire reduces such uncertainty by addressing nineteen different aspects of a person's regular life, including disease status, medications, diet, employment, environmental exposures, and stress, etc., that elevate OS.
Oxidative stress has been shown to be a crucial mechanistic component of AD onset [Liu, et al., 2015; Huang, et al., 2015; Kamat, et al., 2016; Tonnies and Trushina, 2017] and has been definitively associated with brain neuroinflammation and blood-brain barrier dysfunction that is both a cause and consequence of AD generating hyperpermeability that leads to the absorption of as well as generation of OS inducing species in the brain [Zhang & Jiang, 2015; Erickson & Banks, 2013; Najjar, et al., 2013] .
It is also known that disease onset likelihood is related to total oxidative stress arising from numerous sources [Zeliger 2016 and the references contained therein]. These are listed in Appendix (Table I) .
B. Dose Response Relationship
Total Oxidative Stress has been shown to be related to disease onset, whether coming from single sources or from a combination of other sources in a dose response relationship (DRR) [Zeliger, 2016] . A single source example of this effect as it applies to AD is exposure to radon [Lehrer, et al., 2017] . Multiple source examples are lifetime cigarette smoking [Mons, et al., 2013; Durazzo, et al., 2014] and simultaneous exposure to heavy metals and polynuclear aromatic hydrocarbons [Deng, et al., 2019] . DRRs for increased OS include exposures to trichloroethylene, perchloroethylene, air pollution, tobacco smoking, metals (including arsenic, cadmium and mercury), polynuclear aromatic hydrocarbons [Kuang, et al., 2013; Zeliger, 2016] and ultra violet radiation [Agarwal, et al, 1987] .
C. Parameters Known to Increase Likelihood of AD Onset
AD is characterized by deposition of amyloid-beta plaques, hyperphosphorylated tau protein and neurofibrillary tangles [Kamat et al., 2016] . It is well known that elevated oxidative stress is associated with increased likelihood of AD onset [Christen, 2000; Perry, et al., 2002; Huang, et al., 2016 , Durazzo, et al., 2014 , Durazzo, et al., 2014a . The individual parameters and their references are listed in Appendix (Table II) . Oxidative stress has also been shown to be a crucial mechanistic component of AD onset [Liu, et al., 2015; Huang, et al., 2015; Kamat, et al., 2016; Tonnies and Trushina, 2017. Several parameters have been shown to increase the likelihood of AD onset. These and representative references for them are shown in Appendix (Table II) .
D. Aging
Aging is not a disease. Rather, it is a natural consequence of living, but is accelerated by OS. It is widely theorized that excessive OS contained within mitochondria damage the mitochondria which in turn leads to increases in OS. Once started, this cycle leads to further increased OS and aging, making OS both the cause the result of disruption of homeostasis which leads to aging and onset of Alzheimer's disease as well as type 2 diabetes, cardiovascular diseases and COPD [Dato, et al., 2013; Cencioni, at al., 2013; Guillaumet-Adkins, et al., 2017] . As we age, free radicals are excessively generated and overwhelm the body's natural antioxidant response, leading to increased OS [Dato, et al., 2013] . Actions that can be taken to slow down the aging process are discussed in the prevention section below.
E. Genetics and Epigenetics
Genetics and epigenetics have been shown to contribute to the onset of AD. It is well known that AD runs in families and that inheriting one copy of the APOE4 gene triples the risk of developing AD, while inheriting 2 copies of APOE4 increases the risk by 10 to 15 times [Jiang, et al., 2013; Dato, et al., 2013; Guillaumet-Adkins, et al., 2017; Cencioni, et al., 2013] .
Epigenetic changes are heritable changes in gene expression that are not the result of alterations in the DNA sequence. These changes do, however, elevate OS and have been linked to the onset of cardiovascular diseases, respiratory system diseases and neurological system diseases, including AD [Cencioni, et al., 2013; Jiang, et al., 2013; Guillaumet-Adkins, et al., 2017] . The presence of AD in blood relatives has been shown to be associated with greater incidence of the disease, The likelihood of an individual falling ill with AD increases with increasing AD prevalence in parents, grandparents and siblings [National Institute of Aging, 2015] .
F. Co-Morbidities
AD is co-morbid with numerous other diseases. These include hypertension, cardiovascular diseases, type 2 diabetes, ocular disorders, sleep disorders, cognitive and behavioral deficits, bladder and bowel control problems, obesity and musculoskeletal diseases [Barbagallo & Dominguez, 2014; Bannon, 2002; Duthie, et al., 2011; Bunn, et al., 2014; Bauer, et al., 2014; Poblador-Plou, et al., 2014; Fafara, et al., 2014; Zeliger, 2014; Alford et al., 2018; Naderali, et al., 2009; Karki, et al., 2017] Though mechanistic explanations have been offered for some of the co-morbid pairs, AD and T2D or obesity, for example [Profenno, et al., 2009; Barbargallo & Dominguez, 2014; Karki, et al., 2017] , other AD co-morbidities are yet to be mechanistically tied together. However, all of the diseases that are co-morbid with AD are, like AD, known to be caused be elevated OS [Zeliger, 2016] .
G. Late Onset of AD
OS caused diseases manifest themselves only after long term (years) exposure to causative agents. Examples of such diseases are cardiovascular diseases, type 2 diabetes, COPD, cancers and AD. In the case of AD, even early onset of disease, before age 65, follows many years of exposure to OS causing stimuli and in the case of persistent organic pollutants, storage in the body's adipose tissue for up to decades [Cencioni, et al., 2013; Zeliger 2013; Zeliger & Lipinski 2015] .
H. Prevention
Further evidence for the relationship of AD with OS comes from a consideration of lifestyle changes known to lower AD incidence. It is estimated that as many as one half of the cases of AD are attributable to the following eight modifiable factors [Barnes and Yaffe, 2011] . These include:
Acting to prevent and manage type 2 diabetes • Acting to prevent or treat hypertension • Not smoking • Maintaining physical activity • Maintaining cognitive activity • Treating depression, if present • Prevent or reverse obesity
• Maintaining a diet that is low caloric, high in fruits and vegetables, whole grains, and nutritional antioxidants with reduced quantities of carbohydrates, saturated fats, red and processed meats. There are several versions of such a diet. The Mediterranean diet includes the consumption of large quantities of extra virgin olive oil and moderate quantities of red wine [Dato, et al., 2013] . Other examples include the Okinawan diet, (followed by residents of Okinawa, Japan), the Dash diet (developed to stop hypertension) and the Portfolio diet (aimed at reducing cholesterol levels ) [Wilcox, et al., 2014] . It has also been reported that AD prevalence can be significantly reduced by properly treating the following conditions, which undermine immune system vitality and lead to chronic inflammation, which is known to elevate OS [Trempe & Lewis, 2018 , Zeliger, 2017 .
• Chronic migraines
• autoimmune diseases All of the AD causative factors discussed above raise OS, while the preventative factors all lower OS. It is, therefore, reasonably hypothesized that avoiding other OS elevating factors such as chronic infections which stresses the immune system and result in chronic inflammation, as well as chronic environmental exposures to toxic chemicals and radiation, which also elevated OS can delay onset of AD by years. And that is what the OSI does.
I. Questionnaires
Questionnaires, such as the Charlson Comorbidity Index, are routinely used to solicit patient background information on prevalent diseases, symptoms and likelihood of further disease onset [Charlson et al., 1987] . The Alzheimer's Questionnaire is another example [Sabbagh, et al., 2010] .
IV. DISCUSSION
As all of the AD causative factors raise OS, and all the preventative AD factors lower OS, it is, therefore, reasonably hypothesized that avoiding other OS elevating factors such as chronic infections which stresses the immune system and result in chronic inflammation, as well as chronic environmental exposures to toxic chemicals and radiation, which also elevate OS, can delay onset of AD by years.
From the results described above, it is clear that there is no single cause of AD, but that AD onset can be triggered by numerous parameters, all of which are associated with elevating OS.
It is hypothesized here that increased levels of OS is ultimately responsible for increased incidence of AD, that all parameters which contribute to OS elevation increase the likelihood of AD onset and that total OS, measured via the OSI questionnaire administered to the patient or surrogate at the time of first diagnosis of AD can shed light on, not only the patient's total OS, but also, via analysis of statistically significant patient results, on those parameters which are primary contributors to AD onset.
Accordingly, all factors known to raise OS have been incorporated into the modified OSI questionnaire shown in Appendix (Table IIII) . This version of the OSI contains genetic and epigenetic items known to correlate to increased incidence of AD. These are:
As discussed above, exposures to numerous environmental agents have been associated with increased prevalence of AD. These have also been incorporated into the questionnaire.
A. Strengths
The OSI is non-invasive, yet predicts OS levels and offers insights into which parameters are the most contributory to AD onset. Individual items in the OSI are presented in alphabetical order and may differ widely from one item to the next. This is deliberate so that the patient or surrogate addressing the OSI is required to consider each item alone, rather than a part of a series of related questions, which could cause the responder to just check all the items in a single set.
B. Limitations
All parameters in the OSI carry equal weight. Clearly, some parameters are more detrimental to health to others, Parkinson's disease versus the chronic sinusitis, for example. That said, more serious diseases will generally produce greater number of symptoms and require more medications than less severe ones. The large number of items in the OSI, also reduce to importance of any one item to the overall score obtained.
V. CONCLUSIONS
The hypothesis presented here is that AD is an oxidative stress induced disease, as all established causes of AD have been shown to raise OS. Accordingly, anything that raises OS is potentially a contributing cause to AD. Conversely, anything that lowers OS, or prevents raising it, potentially delays or prevents AD onset. It is anticipated that statistical analysis of data collected will shed light on those parameters that most contributory to the onset of AD.
The Oxidative Stress Index measured at time of AD onset is potentially a valuable tool that can lead to an understanding of what the primary causative agents of AD are. Honjo, et al., 2009; D'Aiuto, et al., 2010; Karim, et al., 2014; Sochocka, et al., 2017; Eimer, et al., 2018; Readhead, et al., 2018 Diet Luchsinger, et al., 2002 
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